Ilia I. Ouspenski

Array ( [id] => 8227267 [patent_doc_number] => 20120141466 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-06-07 [patent_title] => 'COMPOSITION AND METHOD FOR TREATMENT OF REPERFUSION INJURY AND TISSUE DAMAGE' [patent_app_type] => utility [patent_app_number] => 12/671810 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23596 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227267 [patent_doc_number] => 20120141466 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-06-07 [patent_title] => 'COMPOSITION AND METHOD FOR TREATMENT OF REPERFUSION INJURY AND TISSUE DAMAGE' [patent_app_type] => utility [patent_app_number] => 12/671810 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23596 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024279 [patent_doc_number] => 20110052605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'ASSAY FOR SOLUBLE CD200' [patent_app_type] => utility [patent_app_number] => 12/936094 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9687 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052605.pdf [firstpage_image] =>[orig_patent_app_number] => 12936094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031923 [patent_doc_number] => 20110081649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'DIAGNOSIS, STAGING AND MONITORING OF INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 12/671318 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3731 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081649.pdf [firstpage_image] =>[orig_patent_app_number] => 12671318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581229 [patent_doc_number] => 20100291085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'ANTIBODIES TO OX-2/CD200 AND USES THEREOF IN INHIBITING IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 12/670379 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 24321 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291085.pdf [firstpage_image] =>[orig_patent_app_number] => 12670379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445360 [patent_doc_number] => 07863422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Anti-PRO87299 antibodies' [patent_app_type] => utility [patent_app_number] => 12/180427 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 39 [patent_no_of_words] => 43464 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863422.pdf [firstpage_image] =>[orig_patent_app_number] => 12180427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545968 [patent_doc_number] => 20090155845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Molecules designated LDCAM' [patent_app_type] => utility [patent_app_number] => 12/218317 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14984 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155845.pdf [firstpage_image] =>[orig_patent_app_number] => 12218317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416405 [patent_doc_number] => 20090042292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'B7-DC Variants' [patent_app_type] => utility [patent_app_number] => 12/171802 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23987 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042292.pdf [firstpage_image] =>[orig_patent_app_number] => 12171802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348876 [patent_doc_number] => 20090004237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'B7-Like Molecules and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/163258 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 36176 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004237.pdf [firstpage_image] =>[orig_patent_app_number] => 12163258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6230084 [patent_doc_number] => 20100184144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'IMMUNOGLOBULIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/664401 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12530 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184144.pdf [firstpage_image] =>[orig_patent_app_number] => 12664401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7728508 [patent_doc_number] => 08101175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-01-24 [patent_title] => 'Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same' [patent_app_type] => utility [patent_app_number] => 12/143077 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16635 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101175.pdf [firstpage_image] =>[orig_patent_app_number] => 12143077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442300 [patent_doc_number] => 07928074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Combination therapy with co-stimulatory factors' [patent_app_type] => utility [patent_app_number] => 12/143693 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 39 [patent_no_of_words] => 38459 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928074.pdf [firstpage_image] =>[orig_patent_app_number] => 12143693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234913 [patent_doc_number] => 20100266617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1' [patent_app_type] => utility [patent_app_number] => 12/663950 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20204 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266617.pdf [firstpage_image] =>[orig_patent_app_number] => 12663950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6426616 [patent_doc_number] => 20100168210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'T-Cell Cytokine-Inducing Surface Molecules and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/663328 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11373 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168210.pdf [firstpage_image] =>[orig_patent_app_number] => 12663328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320584 [patent_doc_number] => 20100196386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'LIGANDS OF HVEM FOR TREATING HEMATOLOGIC MALIGNANCIES AND AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/602539 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19454 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196386.pdf [firstpage_image] =>[orig_patent_app_number] => 12602539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852024 [patent_doc_number] => 20080317766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Costimulatory Molecules and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/128658 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9855 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317766.pdf [firstpage_image] =>[orig_patent_app_number] => 12128658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949862 [patent_doc_number] => 20080305988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'V-Like Domain Binding Molecules' [patent_app_type] => utility [patent_app_number] => 12/120733 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11796 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305988.pdf [firstpage_image] =>[orig_patent_app_number] => 12120733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839366 [patent_doc_number] => 20080279851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'ANTI-ICOS ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/116512 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 90101 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279851.pdf [firstpage_image] =>[orig_patent_app_number] => 12116512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4543357 [patent_doc_number] => 07959916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Negative immunomodulation of immune responses by ERp5' [patent_app_type] => utility [patent_app_number] => 12/108069 [patent_app_country] => US [patent_app_date] => 2008-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 28 [patent_no_of_words] => 22045 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/959/07959916.pdf [firstpage_image] =>[orig_patent_app_number] => 12108069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8005633 [patent_doc_number] => 08084217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'CD161 ligand, pilar, for modulating activation and proliferation of T cells' [patent_app_type] => utility [patent_app_number] => 12/595093 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 12071 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084217.pdf [firstpage_image] =>[orig_patent_app_number] => 12595093 [rel_patent_id] =>[rel_patent_doc_number] =>)